Pharmac funds new cystic fibrosis medicine
McGill spinoff Laurent Pharmaceuticals to begin clinical trial on COVID-19 treatment
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Inhaled Messenger RNA Treatment Fast-Tracked for Cystic Fibrosis
Noninvasive XV Technology May Lead to Faster CF Diagnosis and Better Treatment
New treatment kills off infection that can be deadly to cystic fibrosis patients
SIMPLE TREATMENT OF TYPE 2 DIABETES WITH A LOW-CALORIE DIET IS SO EFFECTIVE THAT IT REVERSES THE DIS
FDA Grants Orphan Drug Status to AR-501, Potential CF Treatment for Chronic Lung Infections
FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR Mutations
Lovelace Biomedical Talks About Developing Novel Therapies for Cystic Fibrosis Month